Cancer Science
Overview
Cancer Science is a renowned scientific journal dedicated to advancing the understanding and treatment of cancer. It publishes cutting-edge research articles, reviews, and perspectives from leading experts worldwide, covering various aspects of cancer biology, genetics, immunology, diagnosis, and therapy. With its rigorous peer-review process, Cancer Science serves as a valuable resource for scientists, clinicians, and policymakers in the fight against cancer.
Details
Details
Abbr.
Cancer Sci
Start
2003
End
Continuing
Frequency
Monthly
p-ISSN
1347-9032
e-ISSN
1349-7006
Country
United Kingdom
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 1149
166
SJR / Ranks: 1707
1625
CiteScore / Ranks: 1313
10.40
JIF / Ranks: 1231
5.7
Recent Articles
1.
Yin J, Luo J, Wang L, Liu L, Liu L
Cancer Sci
. 2025 Mar;
PMID: 40083109
As a multifunctional scavenger receptor, stabilin-1 (STAB1) has been identified to induce chronic inflammation and promote cancer progression. Although in silico studies from multiple data sets showed that STAB1 might...
2.
Yang M, Zhong P, Jiao H, Wei P
Cancer Sci
. 2025 Mar;
PMID: 40083079
This study investigates the molecular mechanisms behind HLA-A*02 subtypes' differential responses to Tecelra, a TCR-engineered T-cell therapy targeting MAGE-A4. Using computational tools, the study identifies specific HLA-A*02 alleles, such as...
3.
Sakamoto S, Inoue H, Takino T, Kohda Y, Yoshida J, Ohba S, et al.
Cancer Sci
. 2025 Mar;
PMID: 40079504
Small-cell lung cancer (SCLC) is an aggressive tumor characterized by the frequent development of distant metastases. This study aimed to explore the mechanism of SCLC metastasis using an originally developed...
4.
Bruce A, Anchondo G, Carter R, Guerrero Pacheco S, Kambala H, Cortez E, et al.
Cancer Sci
. 2025 Mar;
PMID: 40072351
Pharmacologic inhibition of RNA polymerase I activity represents a new therapeutic approach for Ewing sarcoma. This is the first time key components of the ribosome biogenesis pathway have been linked...
5.
Xiao H, Zhou T, Yang Y, Yang X, Bi Y, Cheng X
Cancer Sci
. 2025 Mar;
PMID: 40071783
Long non-coding RNAs (lncRNAs) have emerged as crucial regulators of cancer development and progression. Among them, Differentiation Antagonizing Non-Protein Coding RNA (DANCR) has been implicated in various malignancies, including esophageal...
6.
Xie J, Mellado-Lagarde M, Blankenship K, Ganguly D, Twarog N, Bianski B, et al.
Cancer Sci
. 2025 Mar;
PMID: 40069935
Although primary tumor control rates after surgery and/or radiation therapy (RT) are generally high in patients with Ewing sarcoma (EWS), those with unresectable tumors have failure rates approaching 30% and...
7.
Kawashima M, Yamada T, Miyasaka T, Kanaka S, Kuriyama S, Uehara K, et al.
Cancer Sci
. 2025 Mar;
PMID: 40059633
For patients with resectable colorectal liver metastases (CRLM), the efficacy of adjuvant chemotherapy remains a subject of debate. Several studies have concluded that postoperative circulating tumor DNA (ctDNA) is a...
8.
Zhao Y, Zhao F, Cheng M, Wang G, Wang D, Yin H, et al.
Cancer Sci
. 2025 Mar;
PMID: 40059556
Time-dependent diffusion MRI (t-dMRI) has potential in characterizing microstructural features; however, its value in imaging endometrioid endometrial adenocarcinoma (EEA) remains uncertain. Patients surgically confirmed with EEA were finally enrolled in...
9.
Meng X, Yang X, Zhu J, Chen H, Luo C, Zhang F, et al.
Cancer Sci
. 2025 Mar;
PMID: 40052499
Neutrophils, as key components of the tumor microenvironment, play a crucial role in cancer progression and prognosis. This study aimed to identify a neutrophil-related gene signature to improve prognostic predictions...
10.
Lai X, Yoda H, Qiao Y, Kida Y, Takenaga K, Shinozaki Y, et al.
Cancer Sci
. 2025 Mar;
PMID: 40052411
Amplification of MYCN is a major oncogenic driver of high-risk neuroblastomas. We previously developed CCC-002, a MYCN-selective pyrrole-imidazole polyamide conjugated to a DNA alkylating agent. Administration of CCC-002 to MYCN-amplified...